Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular biomolecules in proximity to photosensitizer refers to the collective group of proteins, lipids, and nucleic acids that undergo oxidative modification during photodynamic therapy (PDT). Because the primary cytotoxic agent in PDT, singlet oxygen, has an extremely short half-life (less than 4 microseconds) and a limited diffusion radius (approximately 10-100 nanometers), the therapeutic effect is strictly confined to the immediate vicinity of the photosensitizer's subcellular localization (Moan & Berg, 1991; Castano et al., 2006). Common targets include mitochondrial enzymes like cytochrome c oxidase, anti-apoptotic proteins such as Bcl-2, and unsaturated fatty acids within organelle membranes (Agostinis et al., 2011). The resulting oxidative damage triggers various cell death pathways, including apoptosis and necrosis, depending on whether the photosensitizer localizes to the mitochondria, lysosomes, or endoplasmic reticulum. This localized mechanism allows for high spatial precision in treating localized cancers and non-malignant conditions while minimizing systemic toxicity (NIH/NCI, 2023). However, the efficacy of targeting these biomolecules is often limited by the availability of molecular oxygen in hypoxic tumor environments and the physical depth to which activating light can penetrate tissue.
Activation of a photosensitizer by specific wavelengths of light leads to a Type II photochemical reaction, which transfers energy to molecular oxygen to generate singlet oxygen. This highly reactive species causes localized oxidative damage to nearby proteins, lipids, and nucleic acids, ultimately triggering cell death (Castano et al., 2006).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular biomolecules in proximity to photosensitizer.